HOTH
Hoth Therapeutics Inc
NASDAQ: HOTH · HEALTHCARE · BIOTECHNOLOGY
$0.71
-2.70% today
Updated 2026-04-29
Market cap
$13.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$0 – $2
Volume
3.1M
Hoth Therapeutics Inc (HOTH) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-1.3%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+50.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.4%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-7.8%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-0.16 | -60.0% | $1.01 | $1.04 | +3.0% |
| 2025-11-12 | $-0.30 | -11.1% | $1.28 | $1.18 | -7.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.10 | $-0.16 | -60.0% | — | — |
| 2025-09-30 | $-0.27 | $-0.30 | -11.1% | — | — |
| 2025-06-30 | $-0.31 | $-0.17 | +45.2% | — | — |
| 2025-03-31 | $-0.34 | $-0.27 | +20.6% | — | — |
| 2024-12-31 | $-0.43 | $-0.32 | +25.6% | — | — |
| 2024-09-30 | $-0.34 | $-0.31 | +8.8% | — | — |
| 2024-06-30 | $-0.43 | $-0.24 | +44.2% | — | — |
| 2024-03-31 | $-0.43 | $-0.46 | -7.0% | — | — |
| 2023-12-31 | $-0.51 | $-0.32 | +37.3% | $59538.00 | — |
| 2023-09-30 | $-0.72 | $-0.60 | +16.7% | — | — |
| 2023-06-30 | $-1.16 | $-0.57 | +51.1% | — | — |
| 2023-03-31 | $-2.29 | $-2.86 | -24.9% | — | — |
Frequently asked questions
Has Hoth Therapeutics Inc beaten earnings estimates?
Hoth Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -1.3% over the last 4 quarters.
How does HOTH stock react to earnings?
HOTH stock has moved an average of -2.4% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.